PT  - JOURNAL ARTICLE
AU  - Zhengbo Duanmu
AU  - Amy Weckle
AU  - Sevasti B. Koukouritaki
AU  - Ronald N. Hines
AU  - Josie L. Falany
AU  - Charles N. Falany
AU  - Thomas A. Kocarek
AU  - Melissa Runge-Morris
TI  - Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver
AID  - 10.1124/jpet.105.093633
DP  - 2006 Mar 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 1310--1317
VI  - 316
IP  - 3
4099  - http://jpet.aspetjournals.org/content/316/3/1310.short
4100  - http://jpet.aspetjournals.org/content/316/3/1310.full
SO  - J Pharmacol Exp Ther2006 Mar 01; 316
AB  - Aryl- (SULT1A1), estrogen- (SULT1E1), and hydroxysteroid- (SULT2A1) sulfotransferases (SULTs) are active determinants of xenobiotic detoxication and hormone metabolism in the adult human liver. To investigate the role of these conjugating enzymes in the developing human liver, the ontogeny of immunoreactive SULT1A1, SULT1E1, and SULT2A1 expression was characterized in a series of 235 pre- and postnatal human liver cytosols ranging in age from early gestation to a postnatal age of 18 years. Interindividual variability in expression levels was apparent for all three SULTs in pre- and postnatal liver samples. Expression of the three SULTs displayed distinctly different developmental profiles. Semiquantitative Western blot analyses indicated that SULT1A1 and SULT2A1 immunoreactive protein levels were readily detectable in the majority of developmental human liver cytosols throughout the prenatal period. Whereas SULT1A1 expression did not differ significantly among the various developmental stages, SULT2A1 expression increased during the third trimester of gestation and continued to increase during postnatal life. By contrast, SULT1E1, a cardinal estrogen-inactivating enzyme, achieved the highest levels of expression during the earliest periods of gestation in prenatal male livers, indicating a requisite role for estrogen inactivation in the developing male. The present analysis suggests that divergent regulatory mechanisms are responsible for the differential patterns of hepatic SULT1A1, SULT1E1, and SULT2A1 immunoreactive protein levels that occur during pre- and postnatal human development, and implicates a major role for sulfotransferase expression in the developing fetus.